Literature DB >> 29882112

Bevacizumab-induced thrombotic microangiopathy and nephrotic syndrome.

Yoshinosuke Shimamura1, Takuto Maeda2, Hideki Takizawa2.   

Abstract

Entities:  

Keywords:  Bevacizumab; Nephrotic syndrome; Thrombotic microangiopathy

Mesh：

Substances：

Year:  2018        PMID： 29882112     DOI： 10.1007/s10157-018-1596-9

Source DB:  PubMed          Journal:  Clin Exp Nephrol        ISSN： 1342-1751            Impact factor:   2.801


× No keyword cloud information.
  5 in total

Review 1.  Bevacizumab increases risk for severe proteinuria in cancer patients.

Authors:  Shenhong Wu; Christi Kim; Lea Baer; Xiaolei Zhu
Journal:  J Am Soc Nephrol       Date:  2010-06-10       Impact factor: 10.121

Review 2.  Podocyte injury and its consequences.

Authors:  Michio Nagata
Journal:  Kidney Int       Date:  2016-03-19       Impact factor: 10.612

3.  VEGF inhibition and renal thrombotic microangiopathy.

Authors:  Vera Eremina; J Ashley Jefferson; Jolanta Kowalewska; Howard Hochster; Mark Haas; Joseph Weisstuch; Catherine Richardson; Jeffrey B Kopp; M Golam Kabir; Peter H Backx; Hans-Peter Gerber; Napoleone Ferrara; Laura Barisoni; Charles E Alpers; Susan E Quaggin
Journal:  N Engl J Med       Date:  2008-03-13       Impact factor: 91.245

4.  Immunoglobulin A nephropathy with massive paramesangial deposits caused by anti-vascular endothelial growth factor therapy for metastatic rectal cancer: a case report and review of the literature.

Authors:  Mayumi Yahata; Izaya Nakaya; Tsutomu Sakuma; Hiroshi Sato; Shigehisa Aoki; Jun Soma
Journal:  BMC Res Notes       Date:  2013-11-09

5.  Kidney diseases associated with anti-vascular endothelial growth factor (VEGF): an 8-year observational study at a single center.

Authors:  Hassan Izzedine; Bernard Escudier; Catherine Lhomme; Patricia Pautier; Philippe Rouvier; Victor Gueutin; Alain Baumelou; Lisa Derosa; Rastilav Bahleda; Antoine Hollebecque; Djillali Sahali; Jean Charles Soria
Journal:  Medicine (Baltimore)       Date:  2014-11       Impact factor: 1.889
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.